brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Genzyme

Schwellenlaender und Genzyme treiben Sanofi-Gewinn zum Jahresauftakt

Friday, April 27th, 2012

Patentverluste druecken Sanofi-Gewinn – Genzyme befluegelt Umsatz

Thursday, July 28th, 2011

Sanofi-Aventis sichert sich Mehrheit am Genzyme

Monday, April 4th, 2011

Genzyme (GENZ) Downgrade from Buy to Hold – Analyst rating from Morgan Joseph

Thursday, February 17th, 2011

Genzyme ( GENZ ) Downgrade from Buy to Hold – Analyst rating from Morgan Joseph

Thursday, February 17th, 2011

Sanofi-Aventis kommt bei Genzyme fuer rund 20,1 Mrd USD zum Zuge

Wednesday, February 16th, 2011

WSJ – Sanofi und Genzyme koennten Mittwoch Uebernahme verkuenden – Kreise

Tuesday, February 15th, 2011

WSJ – Sanofi beendet Due-Diligence-Pruefung von Genzyme – Kreise

Monday, February 14th, 2011

Sanofi verhandelt weiter mit Genzyme – Gewinn schrumpft im 4Q

Wednesday, February 9th, 2011

WSJ – Sanofi bietet 74 USD je Genzyme-Aktie in bar – Kreise

Tuesday, February 1st, 2011

WSJ – Sanofi und Genzyme bei Bedingungen fuer Uebernahme einig – Kreise

Monday, January 31st, 2011

Sanofi und Genzyme schliessen Vertraulichkeitsvereinbarung

Monday, January 31st, 2011

Sanofi-Aventis – Haben Haltung bei Genzyme-Offerte nicht geaendert

Friday, January 14th, 2011

Sanofi-Aventis zu hoeherer Offerte bei Genzyme bereit – Le Figaro

Friday, January 14th, 2011

Sanofi verhandelt ueber erfolgsabhaengige Zahlung bei Genzyme-Kauf

Monday, January 10th, 2011

WSJ – Sanofi, Genzyme loten Gebotspreis von 80 USD je Aktie aus – Kreise

Sunday, January 9th, 2011

WSJ – Genzyme nun zu Gespraechen mit Sanofi bereit – Kreise

Tuesday, December 21st, 2010

Sanofi-Aventis verlaengert Offerte fuer Genzyme

Monday, December 13th, 2010

Sanofi-Aventis droht bei Genzyme-Gebot Konkurrenz – Kreise

Monday, November 15th, 2010

Sanofi wirbt weiterhin vergebens um Genzyme

Tuesday, November 9th, 2010

Genzyme hat kein Interesse an Arbeitsgruppe mit Sanofi

Thursday, October 28th, 2010

WSJ – Arbeitsgruppe soll Sanofi bei Genzyme-Gebot aus Sackgasse helfen

Thursday, October 28th, 2010

Sanofi-Uebernahmeziel Genzyme verfehlt im 3. Quartal Erwartungen

Wednesday, October 20th, 2010

Sanofi-Aventis – USA genehmigen geplante Genzyme-Uebernahme

Wednesday, October 20th, 2010

Sanofi-Aventis wendet sich mit Genzyme-Angebot direkt an Aktionaere

Monday, October 4th, 2010

Genzyme-CEO koennte bei hoeherem Sanofi-Gebot Posten raeumen – FT

Wednesday, September 29th, 2010

WSJ – Sanofi bereitet hoehere Offerte fuer Genzyme vor – Kreise

Monday, September 27th, 2010

Genzyme verkauft Testgeschaeft fuer 925 Mio USD an LabCorp

Monday, September 20th, 2010

Analysten halten Genzyme-Erwartungen an MS-Mittel fuer ueberzogen

Monday, September 20th, 2010

Genzyme ( GENZ ) Downgrade from Outperform to Market Perform($58) – Analyst rating from Mehta Partners

Thursday, July 8th, 2010

Genzyme (GENZ) Downgrade from Outperform to Market Perform – Analyst rating from Mehta Partners

Thursday, July 8th, 2010

Genzyme ( GENZ ) Upgrade from Neutral to Overweight – Analyst rating from Piper Jaffray

Thursday, April 22nd, 2010

Genzyme (GENZ) Upgrade from Mkt Perform to Outperform – Analyst rating from Leerink Swann

Friday, March 26th, 2010

Genzyme ( GENZ ) Upgrade from Mkt Perform to Outperform – Analyst rating from Leerink Swann

Friday, March 26th, 2010

Genzyme ( GENZ ) Downgrade from Neutral to Underweight($45) – Analyst rating from JP Morgan

Thursday, March 25th, 2010

Genzyme ( GENZ ) Initial Recommendation Neutral – Analyst rating from Piper Jaffray

Friday, March 12th, 2010

Genzyme (GENZ) Initial Recommendation – Neutral – Analyst rating from Piper Jaffray

Friday, March 12th, 2010

Genzyme (GENZ) Upgrade from Neutral to Buy – Analyst rating from UBS

Wednesday, February 3rd, 2010

Genzyme (GENZ) Downgrade from Buy to Hold – Analyst rating from Collins Stewart

Friday, December 4th, 2009

Genzyme ( GENZ ) Downgrade from Buy to Hold($55) – Analyst rating from Collins Stewart

Friday, December 4th, 2009

Genzyme ( GENZ ) Downgrade from Buy to Hold($55) – Analyst rating from Collins Stewart

Thursday, December 3rd, 2009

Genzyme (GENZ) Downgrade from Buy to Hold – Analyst rating from Collins Stewart

Thursday, December 3rd, 2009

Genzyme ( GENZ ) Upgrade from Hold to Buy($63) – Analyst rating from Citigroup

Monday, November 30th, 2009

Genzyme (GENZ) Upgrade from Hold to Buy – Analyst rating from Citigroup

Monday, November 30th, 2009

Vertrag mit Genzyme genehmigt

Tuesday, June 2nd, 2009